Breeze Holdings Acquisition Corp.: Nasdaq/NYSE listing notice — Breeze Holdings corrects OTCQX deficiency: rights/warrants only; common stock unaffected

Breeze Holdings Acquisition Corp.

Company received March 17, 2025 OTCQX deficiency for rights (BRZHR) and warrants (BRZHW) under penny stock exemption rules.
Original 8-K incorrectly cited common stock; this amendment corrects that the deficiency pertains only to rights and warrants.
Company has 90 days to cure, until June 13, 2025.
Breeze Holdings expects to close business combination with YD Biopharma Limited before the deadline; combined company would list on NASDAQ.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Breeze Holdings Acquisition Corp. received a otc deficiency notice notice regarding other.

Exchange: otc
Notice: deficiency notice

Exact text from the filing

March 17, 2025, the Company received a notice from OTCQX Market stating that the Company is not in compliance with Section 2 of the Requirements for Continued Qualification of the OTCQX Rules for U.S. Companies (the “OTCQX Rules”). Specifically, the notice referenced a deficiency with respect to the Company’s rights and warrants, trading under the tickers “BRZHR” and “BRZHW” respectively, under Section 1.1(A) of the OTCQX Eligibility Criteria, which requires compliance with certain penny stock exemption requirements. The Original Filing incorrectly referenced the Company’s common stock and war

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001013762-25-000980

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.